237 related articles for article (PubMed ID: 29049434)
1. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
[TBL] [Abstract][Full Text] [Related]
2. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
5. T1-2 glottic cancer treated with radiotherapy and/or surgery.
Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
[TBL] [Abstract][Full Text] [Related]
6. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
7. Surgical vs Nonsurgical Treatment Modalities for T3 Glottic Squamous Cell Carcinoma.
Al-Gilani M; Skillington SA; Kallogjeri D; Haughey B; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2016 Oct; 142(10):940-946. PubMed ID: 27389641
[TBL] [Abstract][Full Text] [Related]
8. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
[TBL] [Abstract][Full Text] [Related]
9. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
10. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal Preservation in Glottic Cancer: A Comparison of Hospital Charges and Morbidity among Treatment Options.
Mandelbaum RS; Abemayor E; Mendelsohn AH
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):265-73. PubMed ID: 27026736
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study of 213 patients with laryngeal cancer].
Miyahara H; Yane K; Tsuruta Y; Uemura H
Nihon Jibiinkoka Gakkai Kaiho; 2002 Jul; 105(7):790-8. PubMed ID: 12174612
[TBL] [Abstract][Full Text] [Related]
13. Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.
Elegbede AI; Rybicki LA; Adelstein DJ; Kaltenbach JA; Lorenz RR; Scharpf J; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1111-7. PubMed ID: 25950990
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
15. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
16. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
17. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
18. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
19. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
